0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Geriatric medicine

Buy Now

Reviews on New Drug Targets in Age-Related Disorders (Paperback, 1st ed. 2020) Loot Price: R4,477
Discovery Miles 44 770
Reviews on New Drug Targets in Age-Related Disorders (Paperback, 1st ed. 2020): Paul C. Guest

Reviews on New Drug Targets in Age-Related Disorders (Paperback, 1st ed. 2020)

Paul C. Guest

Series: Advances in Experimental Medicine and Biology, 1260

 (sign in to rate)
Loot Price R4,477 Discovery Miles 44 770 | Repayment Terms: R420 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Aging is an inevitable part of life and is becoming a worldwide social, economic and health problem. This is mainly due to the fact that the increasing proportion of individuals in the advanced age category have a higher probability of developing age-related disorders, such as type II diabetes mellitus, cardiovascular disorders, sarcopenia, and neurodegenerative conditions. New therapeutic approaches are still needed to decrease or slow the effects of such diseases. Advances in -omic technologies, such as genomics, transcriptomics, proteomics and metabolomics, have significantly advanced our understanding of disease in multiple medical areas, as the analysis of multiple molecular networks has simultaneously provided a more integrated view of disease pathways. It is hoped that emerging hits from these analyses might be prioritized for further screening as potential novel drug targets for increasing the human healthspan in line with the lifespan. In turn, this will lead to new therapeutic strategies as well as drug development projects by the pharmaceutical industry. This book presents a series of reviews describing studies that have resulted in identification of new potential drug targets for age-related disorders. Much of this information has come from -omic comparisons of healthy and disease states or from testing the effects of new therapeutic approaches. Authored by experts from around the globe, each chapter is presented in the context of specific chronic diseases or therapeutic strategies. This book is designed for researchers in the areas of aging and chronic disease, as well as clinical scientists, physicians and stakeholders in major drug companies.

General

Imprint: Springer Nature Switzerland AG
Country of origin: Switzerland
Series: Advances in Experimental Medicine and Biology, 1260
Release date: April 2021
First published: 2020
Editors: Paul C. Guest
Dimensions: 235 x 155mm (L x W)
Format: Paperback
Pages: 340
Edition: 1st ed. 2020
ISBN-13: 978-3-03-042669-9
Categories: Books > Medicine > Clinical & internal medicine > Geriatric medicine
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Science & Mathematics > Biology, life sciences > Biochemistry > Proteins
Books > Science & Mathematics > Biology, life sciences > Cellular biology > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 3-03-042669-6
Barcode: 9783030426699

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners